ArticleAnnals of pediatric cardiology
Early and midterm results of Cook Formula stent in children with right heart disease: A single-center experience.
Article in Annals of pediatric cardiology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Branch pulmonary artery (PA) stenosis must be addressed early to prevent right ventricular scarring and establish lung blood flow. Balloon-mounted stents are more useful in managing right ventricular outflow tract (RVOT) obstruction and PA stenosis. Materials and Methods: We studied the clinical and angiographic data of children with congenital heart disease who underwent stenting for RVOT obstruction and branch PA stenosis using the Formula stent (Cook Medical, Limerick, Ireland) between 2018 and 2024 in a tertiary pediatric cardiac center in southern India. Results: Our patient cohort included 65 patients with a median age of 3 years (range: 3 months to 17 years). The median weight of patients was 11.5 kg (4.8-60.4 kg), with 40% weighing <10 kg. Out of the 87 stents implanted, four stents were implanted in RVOT, while the rest were branch PA stenting. The median stent length was 20 mm (12-60 mm), and the median stent diameter was 10 mm (5-10 mm). All stents were deployed using 5Fr to 8Fr sheaths or guiding catheters. The median procedure time was 62 min (20-170 min), with a median fluoroscopy time of 15 min (4-110 min). A total of 17 (19%) stents in 14 patients required further dilatation at a mean interval of 25 ± 4 months from the time of stenting. Ballooning resulted in an increase in diameter from 7.8 ± 2.2 mm to 10.2 ± 1.7 mm. Right ventricular systolic pressure had reduced from 70.3 ± 8 to 40.1 ± 1 mmHg after balloon dilatation in patients with a biventricular heart. Conclusion: The Formula stent provides a comprehensive stent size option, requiring smaller sheaths, reduced procedural time, minimum complications, and an acceptable rate of reinterventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.